Bonyf NV (MLBON) - Cash Flow Conversion Efficiency

Latest as of March 2021: x

Based on the latest financial reports, Bonyf NV (MLBON) has a cash flow conversion efficiency ratio of x as of March 2021. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€236.51K ≈ $276.51K USD) by net assets (€0.00 ≈ $0.00 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See MLBON defensive asset coverage days to measure how many days the company can operate on defensive assets alone.

Bonyf NV - Cash Flow Conversion Efficiency Trend (2020–2020)

This chart illustrates how Bonyf NV's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Bonyf NV Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Bonyf NV ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aethlon Medical Inc NASDAQ:AEMD	0.000x
OurLiving AB ST:OURLIV	-4.139x
Odd Burger Corp V:ODD	0.012x
Coppermoly Ltd AU:COY	-0.136x
Gabather AB (publ) ST:GABA	-0.117x
Capricorn Energy PLC LSE:CNE	0.335x
NAYA Biosciences, Inc NASDAQ:NAYA	-0.048x
China Pharma Holdings Inc NYSE MKT:CPHI	-0.028x

Annual Cash Flow Conversion Efficiency for Bonyf NV (2020–2020)

The table below shows the annual cash flow conversion efficiency of Bonyf NV from 2020 to 2020. For the full company profile with market capitalisation and key ratios, see Bonyf NV (MLBON) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2020-12-31	€280.06K ≈ $327.42K	€56.95 Million ≈ $66.59 Million	203.364x	--

About Bonyf NV

PA:MLBON France Medical Instruments & Supplies

Market Cap

$2.89 Million

€2.47 Million EUR

Market Cap Rank

#29708 Global

#550 in France

Share Price

€4.20

Change (1 day)

+0.00%

52-Week Range

€3.96 - €13.90

All Time High

€17.80